Good news! SUNBIO was recognized by Shanghai high-tech achievements transformation

A few days ago, the Shanghai Municipal Science and Technology Commission issued the ‘Announcement on the identification of the 6th batch of Shanghai High-Tech Achievements Transformation Projects in 2023’. SUNBIO UP5500 automatic coagulation analyzer project passed acceptance review, expert review and social publicity procedures, won the Shanghai high-tech achievements transformation project identification.

The UP5500 automatic coagulation analyzer independently developed by SUNBIO is mainly used in the prevention, screening, diagnosis and monitoring of thrombotic diseases and bleeding diseases, with the following advantages:

1, PT/APTT/TT/FIB/D-Dimer test speed ≥420 tests/hour, coagulation five comprehensive test speed ≥84 samples/hour, significantly shorten TAT time.

2, APTT correction experiment to achieve automation.

3, HIL intelligent monitoring, super anti-interference.

4. Continuous batch loading of samples, any priority in emergency department.

5, Large capacity cuvette loading system, online addition, continuous detection.

6, The reagent position intelligent intelligent control, comprehensive security.

7, Tilt design, minimum cavity amount.

The high transformation policy effectively guides Shanghai enterprises to carry out technological research and development and accelerate the formation of core competitiveness through independent innovation. In addition to the UP series, Sunbio UR series UR6000 and UR8000 high-speed coagulation analyzers, and UL-2000LAS automatic sample processing system respectively obtained medical device registration certificate and filing certificate, marking the comprehensive layout of Sunbio's high-end coagulation market, providing medical institutions with a comprehensive thrombus and hemostatic product overall solution.